The Anglo-Swedish drugmaker’s closely watched weight loss pill, AZD5004, was well tolerated by patients in an early-stage ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about ...

Investors need to pay close attention to AstraZeneca (AZN) stock based on the movements in the options market lately.

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese ...

AstraZeneca Plc said its experimental obesity pill was well-tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines.

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.

The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD. | As AstraZeneca ...

The Big Pharma companies made a last-ditch effort asking a U.S. appeals court to reconsider their lawsuits against the ...